These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 2163739)
1. [Expression of ras oncogene product P21 in thyroid tumors: an immunohistochemical study]. Gui K Zhonghua Yi Xue Za Zhi; 1990 Mar; 70(3):140-2, 12. PubMed ID: 2163739 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical analysis of the ras oncogene protein product in human thyroid neoplasms. Papadimitriou K; Yiagnisis M; Tolis G; Spandidos DA Anticancer Res; 1988; 8(6):1223-7. PubMed ID: 3064713 [TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical demonstration of ras p21 oncogene product in normal, benign, and malignant human thyroid tissues. Mizukami Y; Nonomura A; Hashimoto T; Terahata S; Matsubara F; Michigishi T; Noguchi M Cancer; 1988 Mar; 61(5):873-80. PubMed ID: 3276392 [TBL] [Abstract][Full Text] [Related]
4. Expression of ras oncogene p21 antigen in normal and proliferative thyroid tissues. Johnson TL; Lloyd RV; Thor A Am J Pathol; 1987 Apr; 127(1):60-5. PubMed ID: 3105323 [TBL] [Abstract][Full Text] [Related]
5. Differential (Ha-, K- and N-) ras p21 expression in benign and malignant human thyroid tumors: an immunohistochemical study. Mizukami Y; Nonomura A; Michigishi T; Noguchi M; Nakamura S; Hashimoto T Anticancer Res; 1995; 15(3):755-9. PubMed ID: 7645954 [TBL] [Abstract][Full Text] [Related]
6. [Immunohistochemical study of ras p21 expression in human gastric cancers and benign lesions]. Nakajima K Hokkaido Igaku Zasshi; 1987 Jul; 62(4):573-80. PubMed ID: 3315926 [TBL] [Abstract][Full Text] [Related]
7. [Expression of protooncogene bcl-2 in thyroid tumors]. Zhu J; Chen Y; Xue H Zhonghua Yi Xue Za Zhi; 1996 Nov; 76(11):829-31. PubMed ID: 9275533 [TBL] [Abstract][Full Text] [Related]
8. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas. Soda G; Antonaci A; Bosco D; Nardoni S; Melis M J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183 [TBL] [Abstract][Full Text] [Related]
9. Comparative immunohistochemical reactivity of monoclonal and polyclonal antibodies to H-ras p21 in normal and neoplastic tissues of rodents and humans. Ward JM; Perantoni AO; Santos E Oncogene; 1989 Feb; 4(2):203-13. PubMed ID: 2648257 [TBL] [Abstract][Full Text] [Related]
10. Enhanced expression of c-Ha-ras p21 in human stomach adenocarcinomas defined by immunoassays using monoclonal antibodies and in situ hybridization. Ohuchi N; Hand PH; Merlo G; Fujita J; Mariani-Costantini R; Thor A; Nose M; Callahan R; Schlom J Cancer Res; 1987 Mar; 47(5):1413-20. PubMed ID: 2434216 [TBL] [Abstract][Full Text] [Related]
11. Detection of activated ras oncogenes in human thyroid carcinomas. Suárez HG; Du Villard JA; Caillou B; Schlumberger M; Tubiana M; Parmentier C; Monier R Oncogene; 1988 Apr; 2(4):403-6. PubMed ID: 3283656 [TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of fatty acid synthase, apoptotic-regulating genes, proliferating factors, and ras protein product in colorectal adenomas, carcinomas, and adjacent nonneoplastic mucosa. Visca P; Alò PL; Del Nonno F; Botti C; Trombetta G; Marandino F; Filippi S; Di Tondo U; Donnorso RP Clin Cancer Res; 1999 Dec; 5(12):4111-8. PubMed ID: 10632348 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical localization of galectin-3 in malignant and benign human thyroid tissue. Cvejic D; Savin S; Paunovic I; Tatic S; Havelka M; Sinadinovic J Anticancer Res; 1998; 18(4A):2637-41. PubMed ID: 9703921 [TBL] [Abstract][Full Text] [Related]
14. Expression of ras and myc oncogenes in human hepatocellular carcinoma and non-neoplastic liver tissues. Tiniakos D; Spandidos DA; Kakkanas A; Pintzas A; Pollice L; Tiniakos G Anticancer Res; 1989; 9(3):715-21. PubMed ID: 2548435 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis of nm23 protein expression in thyroid papillary carcinoma and follicular neoplasm. Tabriz HM; Adabi Kh; Lashkari A; Heshmat R; Haghpanah V; Larijani B; Tavangar SM Pathol Res Pract; 2009; 205(2):83-7. PubMed ID: 18996649 [TBL] [Abstract][Full Text] [Related]
16. Thyroid targeting of the N-ras(Gln61Lys) oncogene in transgenic mice results in follicular tumors that progress to poorly differentiated carcinomas. Vitagliano D; Portella G; Troncone G; Francione A; Rossi C; Bruno A; Giorgini A; Coluzzi S; Nappi TC; Rothstein JL; Pasquinelli R; Chiappetta G; Terracciano D; Macchia V; Melillo RM; Fusco A; Santoro M Oncogene; 2006 Aug; 25(39):5467-74. PubMed ID: 16785999 [TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical detection of RAS, JUN, FOS, and p53 oncoprotein expression in human colorectal adenomas and carcinomas. Magrisso IJ; Richmond RE; Carter JH; Pross CB; Gilfillen RA; Carter HW Lab Invest; 1993 Dec; 69(6):674-81. PubMed ID: 8264230 [TBL] [Abstract][Full Text] [Related]
18. [Immunohistochemical study on oncogene product ras p 21 in thyroid carcinoma]. Mochizuki Y; Nakayama I; Noguchi S Nihon Gan Chiryo Gakkai Shi; 1989 Aug; 24(8):1539-44. PubMed ID: 2681472 [TBL] [Abstract][Full Text] [Related]
19. Preparation of anti-ras Mr 21,000 protein monoclonal antibodies and immunohistochemical analyses on expression of ras genes in human stomach and thyroid cancers. Yoshida K; Hamatani K; Koide H; Ikeda H; Nakamura N; Akiyama M; Tsuchiyama H; Nakayama E; Shiku H Cancer Res; 1988 Oct; 48(19):5503-9. PubMed ID: 3046740 [TBL] [Abstract][Full Text] [Related]
20. Phosphotyrosine, p62 c-myc and p21 c-Ha-ras proteins in colonic epithelium of normal and dimethylhydrazine-treated rats: an immunohistochemical analysis. Schwartz B; Benharroch D; Prinsloo I; Cagnano E; Lamprecht SA Anticancer Res; 1995; 15(1):211-8. PubMed ID: 7537485 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]